Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Pucci WST stock SEC Form 4 insiders trading
Paolo has made over 27 trades of the West Pharmaceutical Services stock since 2008, according to the Form 4 filled with the SEC. Most recently he exercised 1,172,497 units of WST stock worth $5,733,510 on 18 December 2019.
The largest trade he's ever made was exercising 1,172,497 units of West Pharmaceutical Services stock on 18 December 2019 worth over $5,733,510. On average, Paolo trades about 29,932 units every 59 days since 2008. As of 18 December 2019 he still owns at least 1,881,884 units of West Pharmaceutical Services stock.
You can see the complete history of Mr. Pucci stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Paolo Pucci biography
Paolo Pucci serves as Independent Director of the Company. Mr. Pucci is the recently retired CEO and a former member of the Board of Directors of ArQule, Inc.—a biopharmaceutical company engaged in the research and development of targeted therapeutics. Merck & Co. completed its acquisition of ArQule in January 2020, resulting in Mr. Pucci's retirement. Before joining ArQule in 2008, Mr. Pucci worked at Bayer A.G., where he served in several leadership capacities including Senior Vice President of the Global Specialty Medicine Business Unit and was a member of the Bayer Pharmaceuticals Global Management Committee. Before Bayer, Mr. Pucci held positions of increasing responsibility with Eli Lilly and Company, culminating with his appointment as Managing Director, Eli Lilly Sweden AB.
What is the salary of Paolo Pucci?
As the Independent Director of West Pharmaceutical Services, the total compensation of Paolo Pucci at West Pharmaceutical Services is $294,072. There are 17 executives at West Pharmaceutical Services getting paid more, with Eric Green having the highest compensation of $6,533,690.
How old is Paolo Pucci?
Paolo Pucci is 59, he's been the Independent Director of West Pharmaceutical Services since 2016. There are 8 older and 17 younger executives at West Pharmaceutical Services. The oldest executive at West Pharmaceutical Services, Inc. is Patrick Zenner, 73, who is the Independent Chairman of the Board.
What's Paolo Pucci's mailing address?
Paolo's mailing address filed with the SEC is C/O MERUS N.V., UPPSALALAAN 17, UTRECHT, P7, 3584 CT.
Insiders trading at West Pharmaceutical Services
Over the last 19 years, insiders at West Pharmaceutical Services have traded over $32,829,857 worth of West Pharmaceutical Services stock and bought 19,924 units worth $1,139,950 . The most active insiders traders include Robert F Friel, Paolo Pucci a Douglas A Michels. On average, West Pharmaceutical Services executives and independent directors trade stock every 40 days with the average trade being worth of $4,786,805. The most recent stock trade was executed by Charles Witherspoon on 19 August 2024, trading 1,029 units of WST stock currently worth $308,700.
What does West Pharmaceutical Services do?
west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.
What does West Pharmaceutical Services's logo look like?
West Pharmaceutical Services executives and stock owners
West Pharmaceutical Services executives and other stock owners filed with the SEC include:
-
Eric Green,
President, Chief Executive Officer, Director -
Eric M. Green,
Pres, CEO & Director -
Bernard Birkett,
Chief Financial Officer, Senior Vice President -
George Miller,
Senior Vice President, General Counsel, Corporate Secretary -
Bernard J. Birkett,
Sr. VP & CFO -
Silji Abraham,
Senior Vice President and Chief Digital and Transformation Officer -
David Montecalvo,
Senior Vice President, Chief Operating and Supply Chain Officer -
Annette Favorite,
Chief Human Resource Officer, Senior Vice President -
David A. Montecalvo,
Sr. VP and Chief Operations & Supply Chain Officer -
Silji Abraham,
Sr. VP & Chief Technology Officer -
Patrick Zenner,
Independent Chairman of the Board -
Douglas Michels,
Independent Director -
Thomas Hofmann,
Independent Director -
Paula Johnson,
Independent Director -
William Feehery,
Independent Director -
Mark Buthman,
Independent Director -
Myla Lai-Goldman,
Independent Director -
Paolo Pucci,
Independent Director -
Deborah Keller Tanner,
Independent Director -
Chad Winters,
Chief Accounting Officer, Principal Accounting Officer, Vice President, Controller -
Robert Friel,
Independent Director -
Cindy Reiss-Clark,
Senior Vice President of Global Market Units and Commercial Solutions -
Quintin Lai,
Vice President - Corporate Development, Strategy and Investor Relations -
Eric Resnick,
Chief Technology Officer, Vice President -
Richard D. Luzzi,
Sr. VP of HR -
Annette F. Favorite,
Chief HR Officer & Sr. VP -
Michele Polinsky,
VP of Global Communications -
Kimberly Banks MacKay,
Sr. VP, Gen. Counsel & Company Sec. -
Dr. Quintin J. Lai C.F.A., Ph.D.,
VP of Strategy & Investor Relations -
Daniel Malone,
Vice President & Controller -
William J Federici,
VP & CFO -
John H Weiland,
Director -
Karen Flynn,
President, America's Region -
Heino Lennartz,
President Europe -
Anthony Welters,
Director -
Warwick Bedwell,
VP Pharma Pkgs Systems Asia Pa -
John E Paproski,
Vice President-Innovations -
Christopher G Ryan,
President, PPS, Americas -
Rachael M Bushey,
VP, Deputy Gen Coun & Corp Sec -
Jeffrey C Hunt,
VP Pharma Pckg Systems -
John R Gailey,
VP, Gen. Counsel & Sec. -
Richard D Luzzi,
VP, Human Resourses -
L Robert Johnson,
Director -
Michael A Anderson,
Vice President & Treasurer -
Donald E Jr Morel,
Chairman of the Board & CEO -
Robert C Young,
Director -
Donald A Mc Millan,
President Pharma Systems NA -
Steven A Ellers,
Pres., Pharma. Systems Div. -
Geoffrey F Worden,
Director -
John P Neafsey,
Director -
Joseph E Abbott,
Corporate Controller -
Dijk Ronald Van,
President Asia Pacific -
Robert S Hargesheimer,
President-The Tech Group -
Fabio De Sampaio Doria Filho,
Pres., Europe & Asia Pacific -
Matthew T Mullarkey,
Chief Operating Officer -
Robert J Keating,
Pres., Europe & Asia Pacific -
Jenne K Britell,
Director -
Herbert L Hugill,
Pres. of the Americas, Pharma. -
Linda R Altemus,
VP & Chief Compliance Officer -
Molly Joseph,
Director -
Deborah L Keller,
Director -
Stephen H Lockhart,
Director -
Charles Witherspoon,
VP & Treasurer -
Kimberly Banks Mac Kay,
SVP, GC & Corporate Secretary